Company
Utilising world-class technologies in protein science, VVBI focuses on developing/commercialising antibody fragment drugs, antibody/antibody fragment-drug conjugates, structure-based drug design (SBDD), fragment-based drug design (FBDD), affinity selection mass spectrometry (ASMS) screening technology, and membrane protein targeted drug discovery. VVBI services also include target validation, hit identification, lead discovery, in vitro bioassay, as well as therapeutic antibody discovery.
Description
A leading open-access and innovation-driven technology platform company, supporting biotech startups from 0 to 1 and idea to NewCo in a large scale
